The purpose of this article is to provide a data-driven exploration of an interdisciplinary pain rehabilitation program (PRP) as a viable option for addressing the dual crises of chronic pain and opioid use. Psychologists are crucial providers in the PRP, in both intervention and leadership roles. There is well-established literature supporting pain rehabilitation as an effective treatment for chronic pain and functioning, but there are few studies examining the effects of pain rehabilitation on opioid misuse risk. We evaluated data from 60 patients with diverse chronic pain conditions who completed an interdisciplinary PRP to evaluate changes in pain, functioning (self-report and objective physical measure), psychological symptoms, and health-related quality of life. To evaluate the effect of pain rehabilitation on opioid-related risks, we examined opioid use and opioid misuse behaviors (measured by the Current Opioid Misuse Measure; COMM) pre- and posttreatment. Results demonstrated statistically significant improvements in all outcomes, with medium effect sizes for pain severity and large effect sizes for functioning, psychological symptoms, and emotional quality of life. Fifty-eight percent of patients were on opioid medications at entry compared with 15% at discharge. Among patients who entered on opioids, mean COMM scores were significantly reduced from above the cutoff for misuse risk (M = 13.57) to below the cutoff (M = 5.86). Overall, this study provided strong support for pain rehabilitation as an effective treatment for chronic pain and related suffering, while also providing a prevention-based opportunity for reducing opioid-related risk. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

中文翻译：

---

疼痛康复的双重力量：治疗慢性疼痛和预防阿片类药物相关风险。

本文的目的是提供数据驱动的跨学科疼痛康复计划 (PRP) 探索，作为解决慢性疼痛和阿片类药物使用双重危机的可行选择。心理学家在 PRP 中扮演着重要的干预和领导角色。有完善的文献支持疼痛康复作为慢性疼痛和功能的有效治疗方法，但很少有研究检查疼痛康复对阿片类药物滥用风险的影响。我们评估了 60 名完成跨学科 PRP 的不同慢性疼痛患者的数据，以评估疼痛、功能（自我报告和客观身体测量）、心理症状和健康相关生活质量的变化。评估疼痛康复对阿片类药物相关风险的影响，我们检查了治疗前和治疗后的阿片类药物使用和阿片类药物滥用行为（通过当前的阿片类药物滥用措施；COMM 测量）。结果表明，所有结果都有统计学意义的显着改善，疼痛严重程度的影响大小中等，功能、心理症状和情绪生活质量的影响大小大。58% 的患者在入院时服用阿片类药物，而在出院时这一比例为 15%。在使用阿片类药物的患者中，平均 COMM 评分从高于滥用风险的临界值 (M = 13.57) 显着降低至临界值 (M = 5.86) 以下。总体而言，这项研究为疼痛康复作为慢性疼痛和相关痛苦的有效治疗提供了强有力的支持，同时也为降低阿片类药物相关风险提供了基于预防的机会。